Arizti-Sanz, Jon http://orcid.org/0000-0002-4092-9952
Bradley, A’Doriann
Zhang, Yibin B. http://orcid.org/0000-0003-2546-6790
Boehm, Chloe K.
Freije, Catherine A.
Grunberg, Michelle E.
Kosoko-Thoroddsen, Tinna-Solveig F.
Welch, Nicole L.
Pillai, Priya P.
Mantena, Sreekar
Kim, Gaeun
Uwanibe, Jessica N.
John, Oluwagboadurami G.
Eromon, Philomena E.
Kocher, Gregory
Gross, Robin
Lee, Justin S.
Hensley, Lisa E.
MacInnis, Bronwyn L.
Johnson, Jeremy
Springer, Michael
Happi, Christian T.
Sabeti, Pardis C. http://orcid.org/0000-0002-9843-1890
Myhrvold, Cameron http://orcid.org/0000-0002-8971-184X
Article History
Received: 25 October 2021
Accepted: 1 April 2022
First Online: 30 May 2022
Competing interests
: C.A.F., P.C.S. and C.M. are co-inventors on patent PCT/US2018/022764, which covers the SHERLOCK and HUDSON technology for viral RNA detection held by the Broad Institute. J.A.-S., C.A.F., P.C.S. and C.M. are co-inventors on patent PCT/US2021/049145, which covers the SHINE technology for viral RNA detection held by the Broad Institute. M.S. is a co-founder of Rhinostics, Inc., and a shareholder and advisor to the company. P.C.S. is a co-founder of Sherlock Biosciences, Inc., and a shareholder and advisor to the company, as well as a Board member and shareholder of Danaher Corporation. All other authors declare no competing interests.
Free to read: This content has been made available to all.